A Glimpse Into The Knowledgeable Outlook On Vanda Pharma Via 4 Analysts – Vanda Pharma (NASDAQ:VNDA)

Vanda Pharma VNDA has been analyzed by 4 analysts within the final three months, revealing a various vary of views from bullish to bearish.

The desk beneath summarizes their latest scores, showcasing the evolving sentiments inside the previous 30 days and evaluating them to the previous months.

Analysts present deeper insights via their assessments of 12-month value targets, revealing a median goal of $18.0, a excessive estimate of $18.00, and a low estimate of $18.00. No alteration is noticed as the present common stays on the earlier common value goal.

Analyzing Analyst Rankings: A Detailed Breakdown

The standing of Vanda Pharma amongst monetary consultants turns into clear with an intensive evaluation of latest analyst actions. The abstract beneath outlines key analysts, their latest evaluations, and changes to scores and value targets.

Key Insights:

• Motion Taken: In response to dynamic market situations and firm efficiency, analysts replace their suggestions. Whether or not they ‘Keep’, ‘Elevate’, or ‘Decrease’ their stance, it signifies their response to latest developments associated to Vanda Pharma. This perception provides a snapshot of analysts’ views on the present state of the corporate.
• Score: Unveiling insights, analysts ship qualitative insights into inventory efficiency, from ‘Outperform’ to ‘Underperform’. These scores convey expectations for the relative efficiency of Vanda Pharma in comparison with the broader market.
• Value Targets: Analysts discover the dynamics of value targets, offering estimates for the long run worth of Vanda Pharma’s inventory. This examination reveals shifts in analysts’ expectations over time.

Assessing these analyst evaluations alongside essential monetary indicators can present a complete overview of Vanda Pharma’s market place. Keep knowledgeable and make well-judged selections with the help of our Rankings Desk.

Keep updated on Vanda Pharma analyst scores.

If you’re eager about following small-cap inventory information and efficiency you can begin by monitoring it right here.

Discovering Vanda Pharma: A Nearer Look

Vanda Prescription drugs Inc is a biopharmaceutical firm engaged within the improvement and commercialization of therapies to handle excessive unmet medical wants and enhance the lives of sufferers. Its business portfolio contains three merchandise, HETLIOZ for the remedy of Non-24-Hour Sleep-Wake Dysfunction (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the remedy of schizophrenia and PONVORY. Its different merchandise embrace VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The vast majority of income is derived from HETLIOZ product gross sales.

Key Indicators: Vanda Pharma’s Monetary Well being

Market Capitalization: Boasting an elevated market capitalization, the corporate surpasses business averages. This indicators substantial measurement and powerful market recognition.

Income Development: Over the three months interval, Vanda Pharma showcased optimistic efficiency, reaching a income progress charge of 22.76% as of 30 September, 2024. This displays a considerable enhance within the firm’s top-line earnings. When in comparison with others within the Well being Care sector, the corporate faces challenges, reaching a progress charge decrease than the typical amongst friends.

Internet Margin: Vanda Pharma’s monetary energy is mirrored in its distinctive internet margin, which exceeds business averages. With a outstanding internet margin of -11.17%, the corporate showcases sturdy profitability and efficient value administration.

Return on Fairness (ROE): The corporate’s ROE is a standout performer, exceeding business averages. With a formidable ROE of -0.98%, the corporate showcases efficient utilization of fairness capital.

Return on Belongings (ROA): Vanda Pharma’s ROA surpasses business requirements, highlighting the corporate’s distinctive monetary efficiency. With a formidable -0.82% ROA, the corporate successfully makes use of its belongings for optimum returns.

Debt Administration: Vanda Pharma’s debt-to-equity ratio is beneath the business common at 0.01, reflecting a decrease dependency on debt financing and a extra conservative monetary method.

Analyst Rankings: What Are They?

Benzinga tracks 150 analyst companies and experiences on their inventory expectations. Analysts sometimes arrive at their conclusions by predicting how a lot cash an organization will make sooner or later, normally the upcoming 5 years, and the way dangerous or predictable that firm’s income streams are.

Analysts attend firm convention calls and conferences, analysis firm monetary statements, and talk with insiders to publish their scores on shares. Analysts sometimes charge every inventory as soon as per quarter or at any time when the corporate has a significant replace.

Past their commonplace evaluations, some analysts contribute predictions for metrics like progress estimates, earnings, and income, furnishing traders with extra steering. Customers of analyst scores must be aware that this specialised recommendation is formed by human views and could also be topic to variability.

Which Shares Are Analysts Recommending Now?

Benzinga Edge provides you instantaneous entry to all main analyst upgrades, downgrades, and value targets. Kind by accuracy, upside potential, and extra. Click on right here to remain forward of the market.

This text was generated by Benzinga’s automated content material engine and reviewed by an editor.